Results

Total Results: 850 records

Showing results for "considerations".

761. Evidence Summary: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing
     August 20, 2019 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing August 20, 2019 Recommendations made by the USPSTF are independent of the U.S.…

762. Archived: Evidence Summary: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening-june-2018
     June 26, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Osteoporosis to Prevent Fractures: Screening June 26, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They shou…

763. Screening for Gonorrhea: Update of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Wezro6zTSfAWxCrneF-nxB
     May 01, 2005 - gonorrhoeae by recently introduced nonculture tests: a performance review with clinical and public health considerations

764. Archived: Evidence Summary: Human Immunodeficiency Virus (HIV) Infection: Screening, 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2005
     July 05, 2005 - In these groups, treatment considerations, adverse effects from treatment, and natural history may differ

765. Modeling Study: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-study/aspirin-to-prevent-cardiovascular-disease-preventive-medication
     April 26, 2022 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Modeling Study Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication April 26, 2022 Recommendations made by the USPSTF are independent of the U.S. government. …

766. Evidence Summary: Hypertensive Disorders of Pregnancy: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hypertensive-disorders-pregnancy-screening
     September 19, 2023 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Hypertensive Disorders of Pregnancy: Screening September 19, 2023 Recommendations made by the USPSTF are independent of the U.S. government. They should not be…

767. Archived: HIV and Sexually Transmitted Diseases: Behavioral Counseling, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hiv-sexually-transmitted-diseases-behavioral-counseling-1996
     January 01, 1996 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement HIV and Sexually Transmitted Diseases: Behavioral Counseling, 1996 January 01, 1996 Recommendations made by the USPSTF are indep…

768. Modeling Study: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/cervical-cancer-screening
     August 21, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Modeling Study Cervical Cancer: Screening August 21, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an offic…

769. Preventing Dental Caries in Children <5 Years: Systematic Review Updating USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/BM-D2tSCN9U8uuBFAufXaa
     August 01, 2013 - Risk of enamel fluorosis in nonfluoridated and optimally fluoridated populations: considerations for

770. Archived: Final Evidence Summary: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary9/breast-cancer-screening-2009
     November 15, 2009 - Special considerations may be needed, however, for women exposed to additional radiation for other purposes

771. Archived: Final Evidence Summary: Lung Cancer: Screening, May 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary35/lung-cancer-screening-2004
     May 15, 2004 - Considerations in the development of lung cancer screening tools.

772. Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZcuLSXJZXLz9Y2LECTWqVJ
     November 01, 2009 - Special considerations may be needed, however, for women exposed to additional radiation for other purposes

773. Final Evidence Summary: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/drug-use-illicit-screening
     June 09, 2020 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Evidence Summary Unhealthy Drug Use: Screening June 09, 2020 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed …

774. Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/_nVeFxDCT9L-_cnDf_V3fK
     July 17, 2018 - Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the USPSTF Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment Updated Evidence Report and Systematic Review for the US Preventive Services Task Force Jennifer S. Lin, MD, MCR; Co…

775. Screening for HIV: A Review of the Evidence for the U.S. Preventive Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/3qpQqeeozW8nV3a4_BWntp
     June 20, 2019 - In these groups, treatment considerations, adverse effects from treatment, and natural history may differ

776. 10th Annual Report to Congress on High-Priority Evidence Gaps (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/10th-USPSTF-Annual-Report-to-Congress.pdf
     November 01, 2020 - 10th Annual Report to Congress on High-Priority Evidence Gaps High-Priority Evidence Gaps for Clinical Preventive Services 10TH ANNUAL REPORT TO CONGRESS NOVEMBER 2020 SUBMITTED BY: Dr. Alex H. Krist, Chair Dr. Karina W. Davidson, Vice Chair Dr. Carol M. Mangione, Vice Chair ON BEHALF OF THE U.S. PREVENTIV…

777. Archived: Evidence Summary: Drug Use, Illicit: Primary Care Interventions for Children and Adolescents | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary24/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
     March 11, 2014 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Drug Use, Illicit: Primary Care Interventions for Children and Adolescents March 11, 2014 Recommendations made by the USPSTF are independent of …

778. Archived: Evidence Summary: Depression: Screening 2002 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/depression-screening-2002
     May 07, 2002 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Depression: Screening 2002 May 07, 2002 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construe…

779. Final Evidence Summary: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-c-screening
     March 02, 2020 - testing, managing, and treating hepatitis C: overview of cost, reimbursement, and cost-effectiveness considerations

780. Archived: High Blood Cholesterol and Other Lipid Abnormalities: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/high-cholesterol-other-lipid-abnormalities-screening-1996
     January 01, 1996 - measurements based on capillary specimens compared to venous specimens was +4-7%. 55 As a result of these considerations